Therapeutic resistance and optimal drug sequencing in HER2-positive metastatic breast cancer: unmet needs and future perspectives

Autor: Schettini, Francesco, Giudici, Fabiola, Generali, Daniele
Zdroj: In Heliyon 15 January 2024 10(1)
Databáze: ScienceDirect